The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer.
Watanabe H, Kubo T, Ninomiya K, Kudo K, Minami D, Murakami E, Ochi N, Ninomiya T, Harada D, Yasugi M, Ichihara E, Ohashi K, Fujiwara K, Hotta K, Tabata M, Maeda Y, Kiura K.
Watanabe H, et al. Among authors: kubo t.
Jpn J Clin Oncol. 2019 Aug 1;49(8):762-765. doi: 10.1093/jjco/hyz066.
Jpn J Clin Oncol. 2019.
PMID: 31090906